255 related articles for article (PubMed ID: 34468015)
1. miR‑32‑5p suppresses the proliferation and migration of pancreatic adenocarcinoma cells by targeting TLDC1.
Yuan P; Tang C; Chen B; Lei P; Song J; Xin G; Wang Z; Hui Y; Yao W; Wang G; Zhao G
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34468015
[TBL] [Abstract][Full Text] [Related]
2. Long non‑coding RNA PITPNA‑AS1 silencing suppresses proliferation, metastasis and epithelial‑mesenchymal transition in non‑small cell lung cancer cells by targeting microRNA‑32‑5p.
Chen G; Zheng Z; Li J; Zhang P; Wang Z; Guo S; Ma J; Shen J; Li H
Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33495838
[TBL] [Abstract][Full Text] [Related]
3. LncRNA LINC00857 strengthens the malignancy behaviors of pancreatic adenocarcinoma cells by serving as a competing endogenous RNA for miR-340-5p to upregulate TGFA expression.
Li T; Zhao H; Zhou H; Geng T
PLoS One; 2021; 16(3):e0247817. PubMed ID: 33661995
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of long non-coding RNA LINC00460 inhibits the proliferation, migration and invasion, and promotes apoptosis of pancreatic cancer cells via modulation of the miR-320b/ARF1 axis.
Cheng J; Lou Y; Jiang K
Bioengineered; 2021 Dec; 12(1):96-107. PubMed ID: 33345740
[TBL] [Abstract][Full Text] [Related]
5. LINC00941 promotes proliferation and metastasis of pancreatic adenocarcinoma by competitively binding miR-873-3p and thus upregulates ATXN2.
Fang L; Wang SH; Cui YG; Huang L
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1861-1868. PubMed ID: 33660796
[TBL] [Abstract][Full Text] [Related]
6. LncRNA MBNL1-AS1 Suppresses Cell Proliferation and Metastasis of Pancreatic Adenocarcinoma through Targeting Carcinogenic miR-301b-3p.
Sulidankazha C; Alidake ; Lin H; He T; Han W; Chen Q
Genet Res (Camb); 2023; 2023():6785005. PubMed ID: 36908851
[TBL] [Abstract][Full Text] [Related]
7. FUBP1 mediates the growth and metastasis through TGFβ/Smad signaling in pancreatic adenocarcinoma.
Zhang Y; Chen J; Zhou N; Lu Y; Lu J; Xing X; Chen H; Zhang X
Int J Mol Med; 2021 May; 47(5):. PubMed ID: 33649780
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA SNHG17 contributes to the progression of pancreatic adenocarcinoma by modulating miR-32-5p/EZH2/STAT3 signaling.
Ying L; Wang J; Feng J; Wu Z
Mol Biol Rep; 2023 Jul; 50(7):5941-5947. PubMed ID: 37253918
[TBL] [Abstract][Full Text] [Related]
9. PLAGL1 is associated with prognosis and cell proliferation in pancreatic adenocarcinoma.
Liang X; Fu Z; Tang L; Zheng M; Chen D; Liu A; Shi L; Yang L; Shao C; Dong X
BMC Gastroenterol; 2023 Jan; 23(1):2. PubMed ID: 36600208
[TBL] [Abstract][Full Text] [Related]
10. CSN6 inhibition suppresses pancreatic adenocarcinoma metastasis via destabilizing the c-Fos protein.
Ma F; Wang H; Liu K; Wang Z; Chen S
Exp Cell Res; 2020 Jun; 391(1):112004. PubMed ID: 32289284
[TBL] [Abstract][Full Text] [Related]
11. SQLE, A Key Enzyme in Cholesterol Metabolism, Correlates With Tumor Immune Infiltration and Immunotherapy Outcome of Pancreatic Adenocarcinoma.
You W; Ke J; Chen Y; Cai Z; Huang ZP; Hu P; Wu X
Front Immunol; 2022; 13():864244. PubMed ID: 35720314
[TBL] [Abstract][Full Text] [Related]
12. COL10A1 promotes tumorigenesis by modulating CD276 in pancreatic adenocarcinoma.
Xu Q; Zheng J; Su Z; Chen B; Gu S
BMC Gastroenterol; 2023 Nov; 23(1):397. PubMed ID: 37974070
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation and miR-92a-3p-mediated repression of HIP1R promotes pancreatic cancer progression by activating the PI3K/AKT pathway.
Zhu S; Xu H; Chen R; Shen Q; Yang D; Peng H; Tong J; Fu Q
J Cell Mol Med; 2023 Mar; 27(6):788-802. PubMed ID: 36811277
[TBL] [Abstract][Full Text] [Related]
14. Ginsenoside Rg3 suppresses vasculogenic mimicry by impairing DVL3-maintained stemness via PAAD cell-derived exosomal miR-204 in pancreatic adenocarcinoma.
Cai X; Wang Z; Lin S; Chen H; Bu H
Phytomedicine; 2024 Apr; 126():155402. PubMed ID: 38350242
[TBL] [Abstract][Full Text] [Related]
15. Overexpressed CA12 has prognostic value in pancreatic cancer and promotes tumor cell apoptosis via NF-κB signaling.
Du Y; Xin Z; Liu T; Xu P; Mao F; Yao J
J Cancer Res Clin Oncol; 2021 May; 147(5):1557-1564. PubMed ID: 33387040
[TBL] [Abstract][Full Text] [Related]
16.
Kuang W; Wang X; Ding J; Li J; Ji M; Chen W; Wang L; Yang P
Front Immunol; 2022; 13():805311. PubMed ID: 35154122
[TBL] [Abstract][Full Text] [Related]
17. Long non‑coding RNA TTN‑AS1 regulates the proliferation, invasion and migration of triple‑negative breast cancer by targeting miR‑211‑5p.
Sun E; Liu X; Lu C; Liu K
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179096
[TBL] [Abstract][Full Text] [Related]
18. LINC01232 Sponges Multiple miRNAs and Its Clinical Significance in Pancreatic Adenocarcinoma Diagnosis and Prognosis.
Du W; Lei C; Wang Y; Ding Y; Tian P
Technol Cancer Res Treat; 2021; 20():1533033820988525. PubMed ID: 33506742
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological features, prognostic significance, and associated tumor cell functions of family with sequence similarity 111 member B in pancreatic adenocarcinoma.
Gong Q; Dong Q; Zhong B; Zhang T; Cao D; Zhang Y; Ma D; Cai X; Li Z
J Clin Lab Anal; 2022 Dec; 36(12):e24784. PubMed ID: 36408702
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of CBX3 in Pancreatic Adenocarcinoma Promotes Cell Cycle Transition-Associated Tumor Progression.
Chen LY; Cheng CS; Qu C; Wang P; Chen H; Meng ZQ; Chen Z
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29903985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
